CNTB · Connect Biopharma Holdings Ltd
United States · RS rating 9 · As of 2026-11-03
| Price | 0.77 USD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 9 / 29 / 5 / 19 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 23 / 9 / 25 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +12.9% |
| Sales growth Q/Q | -100.0% |
| Distance from 52-week high | +79.0% |
| Market cap (USD) | $142.4M |